Ross Radusky, MD
Dermatology · Dallas, TXNPI 1508209206
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,008,063 of the $1,163,310 with a category attached, or 86.7%. Merz North America, Inc. accounts for 78.1% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $569,355, more than ten times the $312 reported in 2019. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 965 payments — averaging $1205.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$908K
- Arcutis Biotherapeutics, Inc.$100K
- LEO Pharma Inc.$81K
- Kowa Pharmaceuticals America, Inc.$29K
- Organon$16K
- Dermavant Sciences, Inc.$10K
- plus $18K from 23 others
Across 940 payments — averaging $2265.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$776K
- Incyte Corporation$410K
- Sanofi US Services Inc.$178K
- Merz North America, Inc.$151K
- Teva Pharmaceuticals USA, Inc.$117K
- Pfizer$111K
- plus $387K from 8 others
What the payments were for
- Consulting fees$1,008,06387%
- Speaking & faculty fees$88,0918%
- Travel & lodging$47,2914%
- Food & beverage$19,6512%
- Education$2150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 61 | $908,098 |
| Arcutis Biotherapeutics, Inc. | 157 | $100,073 |
| LEO Pharma Inc. | 134 | $81,306 |
| Kowa Pharmaceuticals America, Inc. | 27 | $29,422 |
| Organon | 20 | $15,780 |
| Dermavant Sciences, Inc. | 51 | $10,475 |
| Johnson & Johnson | 83 | $4,659 |
| Incyte Corporation | 26 | $3,772 |
| Pfizer | 37 | $1,922 |
| AbbVie(2 entities) | 92 | $1,523 |
| Sanofi | 36 | $934 |
| Sun Pharmaceutical Industries Inc. | 45 | $891 |
| Galderma Laboratories, L.p. | 21 | $677 |
| Lilly USA, LLC | 23 | $563 |
| UCB, Inc. | 20 | $493 |
| Novartis | 26 | $441 |
| Regeneron Healthcare Solutions, Inc. | 21 | $436 |
| Almirall LLC | 11 | $406 |
| Amgen | 19 | $381 |
| E.r. Squibb & Sons, L.L.C. | 26 | $380 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $167 |
| Strata Skin Sciences, Inc. | 4 | $99 |
| Janssen Scientific Affairs, LLC | 3 | $96 |
| Bristol Myers Squibb | 1 | $91 |
| Boehringer Ingelheim | 3 | $87 |
| Botanix SB Inc | 2 | $49 |
| Mayne Pharma Commercial LLC | 3 | $46 |
| EPI Health, LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,163,310 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 23 | $158,276 |
| Dupixent SyringeDupilumab | 28 | $149,388 |
| Dupixent PenDupilumab | 12 | $44,877 |
| Acitretin | 13 | $3,371 |
| Clobetasol Propionate | 94 | $3,299 |
| Triamcinolone Acetonide | 117 | $1,255 |
| Halobetasol Propionate | 12 | $955 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 19 | $942 |
| Ketoconazole | 53 | $928 |
| Fluorouracil | 12 | $834 |
| Mupirocin | 41 | $367 |
| ValacyclovirValacyclovir Hcl | 13 | $322 |
| Hydrocortisone | 34 | $150 |
| Minoxidil | 13 | $84 |
| Spironolactone | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dallas
- Jennifer CatherDallas$1.3M
- Joseph MerolaDallas$1.2M
- So Yeon PaekDallas$812K
- Martin MenterDallas$512K
- Mary HornerDallas$448K
- Donald GlassDallas$347K
- William AbramovitsDallas$325K
- Mary FleischliDallas$153K
- Adean KingstonDallas$141K
- Edward LainAustin$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.